Literature DB >> 22219304

Pseudo-outbreak of extremely drug-resistant pseudomonas aeruginosa urinary tract infections due to contamination of an automated urine analyzer.

M Hallin1, A Deplano, S Roisin, V Boyart, R De Ryck, C Nonhoff, B Byl, Y Glupczynski, O Denis.   

Abstract

By the end of May 2010, an increase in the number of urine specimens that were culture positive for extremely drug-resistant (XDR) Pseudomonas aeruginosa was observed in our 800-bed university hospital. This led to an infection control alert. No epidemiological link between the patients and no increase in the frequency of XDR P. aeruginosa in non-urine samples were observed. Therefore, a pseudo-outbreak due to analytical contamination in the laboratory was rapidly suspected. A prospective and retrospective search of cases was initiated, and the sampling of the automated urine analyzers used in the laboratory was performed. Antibiotypes were determined by disc diffusion, and genotypes were determined by pulsed-field gel electrophoresis (PFGE). From February to July 2010, 17 patients admitted to 12 different departments and 6 outpatients were included. The mixing device of the cytometric analyzer used for the numeration of urinary particles (Sysmex UF1000i) proved to be heavily contaminated. Isolates recovered from 12 patients belonged to the same antibiotype and PFGE type as the isolate recovered from the analyzer. Extensive disinfection with a broad-spectrum disinfectant and the replacement of the entire tubing was necessary to achieve the complete negativity of culture samples taken from the analyzer. A pseudo-outbreak caused by an XDR P. aeruginosa clone was proven to be due to the contamination of the cytometric analyzer for urinary sediment. Users of such analyzers should be aware that contamination can occur and should always perform culture either before the processing of the urine sample on the analyzer or on a distinct sample tube.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22219304      PMCID: PMC3295159          DOI: 10.1128/JCM.06268-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Emergence and dissemination of multidrug resistant clones of Pseudomonas aeruginosa producing VIM-2 metallo-beta-lactamase in Belgium.

Authors:  A Deplano; H Rodriguez-Villalobos; Y Glupczynski; P Bogaerts; D Allemeersch; A Grimmelprez; G Mascart; L Bergès; B Byl; C Laurent; M J Struelens
Journal:  Euro Surveill       Date:  2007-01-18

2.  Nosocomial infections caused by multidrug-resistant Pseudomonas putida isolates producing VIM-2 and VIM-4 metallo-beta-lactamases.

Authors:  Pierre Bogaerts; Te-Din Huang; Hector Rodriguez-Villalobos; Caroline Bauraing; Ariane Deplano; Marc J Struelens; Youri Glupczynski
Journal:  J Antimicrob Chemother       Date:  2008-01-31       Impact factor: 5.790

3.  Screening for urinary tract infection with the Sysmex UF-1000i urine flow cytometer.

Authors:  Maarten A C Broeren; Semiha Bahçeci; Huib L Vader; Niek L A Arents
Journal:  J Clin Microbiol       Date:  2011-01-19       Impact factor: 5.948

4.  Pseudo-outbreak of Pseudomonas aeruginosa and Serratia marcescens related to bronchoscopes.

Authors:  Cláudia V Silva; Vanda D Magalhães; Crésio R Pereira; Julia Y Kawagoe; Chizue Ikura; Arnaldo J Ganc
Journal:  Infect Control Hosp Epidemiol       Date:  2003-03       Impact factor: 3.254

5.  Detection and characterization of class A extended-spectrum-beta-lactamase-producing Pseudomonas aeruginosa isolates in Belgian hospitals.

Authors:  Y Glupczynski; P Bogaerts; A Deplano; C Berhin; T-D Huang; J Van Eldere; H Rodriguez-Villalobos
Journal:  J Antimicrob Chemother       Date:  2010-03-03       Impact factor: 5.790

6.  Outbreak of carbapenem-resistant Pseudomonas aeruginosa infection in a surgical intensive care unit.

Authors:  A Kohlenberg; D Weitzel-Kage; P van der Linden; D Sohr; S Vögeler; A Kola; E Halle; H Rüden; K Weist
Journal:  J Hosp Infect       Date:  2010-02-19       Impact factor: 3.926

7.  Pseudo-outbreak of multiresistant Pseudomonas aeruginosa in a hematology unit.

Authors:  P E Verweij; D Bijl; W J Melchers; B E De Pauw; J F Meis; J A Hoogkamp-Korstanje; A Voss
Journal:  Infect Control Hosp Epidemiol       Date:  1997-02       Impact factor: 3.254

8.  Outbreak of Pseudomonas aeruginosa infection associated with contamination of a flexible bronchoscope.

Authors:  Carlos A DiazGranados; Marolyn Y Jones; Thiphasone Kongphet-Tran; Nancy White; Mark Shapiro; Yun F Wang; Susan M Ray; Henry M Blumberg
Journal:  Infect Control Hosp Epidemiol       Date:  2009-06       Impact factor: 3.254

9.  Investigation of a pseudo-outbreak of orthopedic infections caused by Pseudomonas aeruginosa.

Authors:  W Forman; P Axelrod; K St John; J Kostman; C Khater; J Woodwell; R Vitagliano; A Truant; V Satishchandran; T Fekete
Journal:  Infect Control Hosp Epidemiol       Date:  1994-10       Impact factor: 3.254

10.  Pseudomonas aeruginosa population structure revisited.

Authors:  Jean-Paul Pirnay; Florence Bilocq; Bruno Pot; Pierre Cornelis; Martin Zizi; Johan Van Eldere; Pieter Deschaght; Mario Vaneechoutte; Serge Jennes; Tyrone Pitt; Daniel De Vos
Journal:  PLoS One       Date:  2009-11-13       Impact factor: 3.240

View more
  3 in total

1.  Characterization of a Tsukamurella pseudo-outbreak by phenotypic tests, 16S rRNA sequencing, pulsed-field gel electrophoresis, and metabolic footprinting.

Authors:  Kelvin K W To; Ami M Y Fung; Jade L L Teng; Shirly O T Curreem; Kim-Chung Lee; Kwok-Yung Yuen; Ching-Wan Lam; Susanna K P Lau; Patrick C Y Woo
Journal:  J Clin Microbiol       Date:  2012-11-07       Impact factor: 5.948

2.  Investigation of a Candida guilliermondii Pseudo-outbreak Reveals a Novel Source of Laboratory Contamination.

Authors:  James E Kirby; Westyn Branch-Elliman; Mary T LaSalvia; Lorinda Longhi; Matthew MacKechnie; Grigoriy Urman; Linda M Baldini; Fatima R Muriel; Bernadette Sullivan; David S Yassa; Howard S Gold; Trevor K Wagner; Daniel J Diekema; Sharon B Wright
Journal:  J Clin Microbiol       Date:  2017-01-18       Impact factor: 5.948

Review 3.  A systematic review and meta-analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem-resistant Pseudomonas aeruginosa.

Authors:  Anne F Voor In 't Holt; Juliëtte A Severin; Emmanuel M E H Lesaffre; Margreet C Vos
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.